Translational Development Acquisition Corp. (TDAC)
Nasdaq · Financial Services · Shell Companies
$10.83+0.05%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $209M
- P/E (trailing)
- 41.6
- 52-week range
- $10.35 – $10.95
- 52-week change
- +4.54%
- EPS (trailing)
- $0.26
Fiscal year to Dec 2025
- Net income
- $6.4M
From the company’s annual report on SEC EDGAR.
About Translational Development Acquisition Corp.
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Headquarters: New York, United States · translational-development.com